Luca Roncati | Medicine and Dentistry | Best Researcher Award

Published on by Phenomenological Research Awards

Prof. Luca Roncati | Medicine and Dentistry | Best Researcher Award  

Professor at Link Campus University | Italy

Prof. Luca Roncati is an accomplished Italian physician-scientist, pathologist, and academic who has made outstanding contributions to medicine and dentistry through his pioneering research, teaching, and clinical leadership. He earned his Ph.D. in Pathology, building a solid academic foundation that has enabled him to excel in translational research across multiple domains including senology, gynecologic oncology, gynecopathology, and hematopathology. Currently, he serves as a Full Professor of Pathology at Link Campus University in Rome and as Head of the Women’s Health Department at the European Institute of Dermatology in Milan, where he integrates patient care with innovative research. His professional experience also extends to forensic pathology and editorial responsibilities, highlighting his multidisciplinary expertise and leadership in the scientific community. Prof. Luca Roncati’s research interests span cancer biology, nanopathology, women’s health, and infectious diseases, with significant contributions to the understanding of COVID-19 pathology, exemplified by several highly cited publications. His skills include advanced diagnostic pathology, molecular biology, nanotechnology applications in medicine, and academic mentorship, as well as the ability to translate complex findings into practical healthcare solutions. With over 227 publications, 1,726 citations by 1,064 documents, and an h-index of 23, his academic output reflects sustained global impact and recognition. His innovative work includes the description of the Roncati-Manenti triad and T rex lymphoma, and his authorship of more than 280 peer-reviewed publications in high-impact journals has positioned him as a global thought leader. Prof. Luca Roncati has received numerous honors as an award-winning author and inventor of anti-cancer patents, underscoring his capacity to merge science with innovation. In conclusion, Prof. Luca Roncati’s distinguished academic record, clinical leadership, and groundbreaking contributions to oncology, nanopathology, and women’s health make him a leading figure in medicine whose continued work promises to advance medical research, patient care, and global health standards.

Profile: Scopus

Featured Publications:

  1. Roncati, L. (2020). The COVID-19 syndrome: a clinical perspective. Clinical Immunology, 215, 108487.

  2. Roncati, L. (2020). Endothelial–platelet interactions in COVID-19. Annals of Hematology, 99(9), 1955–1956.

  3. Roncati, L. (2020). T rex lymphoma: a novel hematologic entity. Current Medical Research and Opinion, 36(3), 511–514.

  4. Roncati, L. (2017). Nanopathology: the health impact of nanoparticles. Nanotoxicology, 11(7), 884–888.

  5. Roncati, L. (2016). The Roncati–Manenti triad in gynecologic oncology. International Journal of Gynecological Cancer, 26(8), 1584–1585.

  6. Roncati, L. (2019). The forensic challenges in the study of nanoparticle exposure. Forensic Science International, 301, 309–315.

  7. Roncati, L. (2018). Molecular pathology insights into breast cancer. Pathology Research and Practice, 214(12), 2000–2005.